AgeX Therapeutics, Inc. (AGE)

EPS Growth

16.67%

Quarterly · Period ending:

AGE logo

AGE EPS Growth

Year-over-year change vs the same period a year earlier

Latest reported16.67%
AGE Quarterly EPS YoY % (-1217.39% → 16.67%)
High-resolution chart · PNG

AGE eps growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EPS Growth — Quarterly
Period endingEPS Growth
16.6667%
-18.3673%
0%
-381.25%
-208.1967%
75.1269%
90.3125%
103.1936%
124.6964%
61.3725%
-27.49%
-62.6623%
26.9231%
-63.4615%
-25.5%
-70.1657%
-47.5983%
-60%
11.8943%
23.3051%
8.4%
34.1216%
9.9206%
21.0702%
12.892%
2.3102%
18.9711%
-42.381%
-45.6853%
-1,217.3913%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.